Tangany, based in Munich, is a highly innovative technology company with a market-leading B2B solution for the custody of digital assets on the blockchain (e.g. cryptocurrencies, tokenized assets, NFTs). Our solution is already used by more
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)